Source: International Congress 2015 – Non-tuberculous mycobacteria and molecular microbiology
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
Marko Jakopovic (Zagreb, Croatia), Mateja Jankovic Makeke, Ivan Sabol, Jakko Van Ingen, Marko Jakopovic, Ljiljana Zmak, Andrea Vukic Dugac, Ana Hecimovic, Daniel Sekula, Drazen Strelec, Dina Mihelcic, Miroslav Samarzija. Systemic corticosteroid and inhalation corticosteroid therapy are associated with nontuberculous mycobacterial pulmonary disease. Eur Respir J 2015; 46: Suppl. 59, 2679

Member's Comments

No comment yet.

Related content which might interest you: Safety of intravenous amikacin in the treatment of pulmonary non-tuberculous mycobacterial disease Source: Annual Congress 2013 –Non-tuberculous mycobacteria: clinical management Year: 2013 Pulmonary nocardiosis (PN) complicating chronic pulmonary diseases Source: International Congress 2014 – Epidemiology, scores and outcomes of respiratory infections Year: 2014 Clinical analysisof patients with pulmonary nontuberculous mycobacterial disease complicated with pneumothorax Source: Annual Congress 2013 –Non-tuberculous mycobacteria: clinical management Year: 2013 Risk factors and treatment outcomes in patients with chronic pulmonary aspergillosis Source: International Congress 2016 – Severe respiratory infections in the intensive care unit and pleural and fungal infections Year: 2016 Clinical characteristics of pulmonary nocardiosis in immunocompetent patients Source: International Congress 2015 – Bronchiectasis and NTM infections: clinical and functional characterisation Year: 2015 Prolonged oral corticosteroid therapy in allergic bronchopulmonary aspergillosis (ABPA) treatment does not increase pseudomonas aeruginosa risk Source: International Congress 2015 – Cystic fibrosis: microbiology, immunology and assessment Year: 2015 Cavitary formation in non-tuberculous mycobacterial infection is the significant risk for development to chronic pulmonary aspergillosis Source: International Congress 2014 – Cells, biofilms and biomarkers in respiratory infections Year: 2014 Clinical characteristics and prognosis of chronic pulmonary aspergillosis Source: International Congress 2014 – Different interesting issues in respiratory infections: 2 Year: 2014 Systemic corticosteroid for treating severe community-acquired pneumonia Source: International Congress 2015 – Advances in pneumonia management, COPD therapy and lung nodule evaluation Year: 2015 Perspectives on antibiotic treatment of NTM pulmonary disease Source: Eur Respir Monogr 2017; 75: 245-252 Year: 2017 Risk of pneumonia in chronic obstructive pulmonary disease patients treated with inhaled corticosteroids. Results from the OUTPUL study Source: International Congress 2016 – Comorbidities and exacerbations in COPD Year: 2016 Inhaled corticosteroids and the increased risk of non-tuberculous mycobacteria infection Source: International Congress 2019 – Exploring the link between inhaled corticosteroids and respiratory infection Year: 2019 Nontuberculous mycobacterial infection in chronic obstructive pulmonary disease Source: International Congress 2015 – The relevance of diagnostic and monitoring tools in clinical practice Year: 2015 Pulmonary and systemic inflammatory response in patients with pulmonary infections receiving long-term glucocorticoid therapy Source: Eur Respir J 2002; 20: Suppl. 38, 15s Year: 2002 Nontuberculous mycobacteria in cystic fibrosis associated with allergic bronchopulmonary aspergillosis and steroid therapy Source: Eur Respir J 2005; 25: 324-328 Year: 2005 Evaluation of tuberculosis risk in patients submitted to chronic immunosuppressive therapy for osteoarticular immune disease Source: Eur Respir J 2006; 28: Suppl. 50, 131s Year: 2006 Severe pulmonary infections due to biological therapy of rheumatic diseases Source: Annual Congress 2011 - Infection in the immunocompromised host: infrequent aetiologies Year: 2011 Impact of inhaled corticosteroid use on outcome in COPD patients admitted with pneumonia Source: Eur Respir J 2011; 37: 36-41 Year: 2011 Concomitant intestinal parasitic infections in patients with respiratory disease Source: Annual Congress 2013 –Lung infections: a clinical point of view Year: 2013 Recurrent respiratory papillomatosis - rapid response to systemic bevacizumab Source: Annual Congress 2013 –Clinical management of orphan lung diseases Year: 2013